Hematology/Oncology Clinical Pharmacy Specialist Penn Medicine Cherry Hill , New Jersey, United States
Disclosures:
Oxana Megherea has served on an advisory board for BioLineRx.
Learning Objectives:
Recall the approved label indications of new drugs and biologics in hematology/oncology
Match the names of new and emerging oncology drugs with their mechanisms of action
Safely manage treatment-related adverse events in patients receiving newly approved drugs and biologics in hematology/oncology, especially bispecific antibodies
